Duality Biologics and BioNTech Highlight Interim Data from P-I/IIa Trial of BNT324/DB-1311 in Advanced Solid Tumors at ESMO Asia 2...
Shots: The P-I/IIa study assessed BNT324 (B7-H3 targeting ADC) in heavily pretreat...
Daiichi Sankyo Reports Pooled Analysis from TROPION-Lung05 & TROPION-Lung01 Trials of Datopotamab Deruxtecan (Dato-DXd) for NSCLC
Shots: Daiichi Sankyo reported pooled analysis from P-II (
VivaVision Biotech Reports Topline Results from P-II Study of VVN461 for Post-Operative Inflammation Following Cataract Surgery
Shots: The P-II trial assessed VVN461 (1.0% & 0.5%) vs vehicle for post-catara...
Eli Lilly Reports Results from the P-IIIb (SURMOUNT-5) Trial of Zepbound (Tirzepatide) in Obese Adults
Shots: Eli Lilly reported topline data from P-IIIb (
Everest Medicines Reports Results from the P-Ib/IIa Study of EVER001 to Treat Primary Membranous Nephropathy
Shots: The P-Ib/IIa study assessed EVER001 (XNW1011) to treat patients (n=31) with...
InventisBio Reports Results from the P-II Trial of D-2570 to Treat Moderate to Severe Plaque Psoriasis
Shots: InventisBio has reported the results from P-II study assessing the safety &...
